Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Unknown 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 17 Melanoma 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Breast Neoplasms 4 Urinary Bladder Neoplasms 3 Stomach Neoplasms 2 Mesothelioma, Malignant 2 Head and Neck Neoplasms 2 Gastrointestinal Neoplasms 2 Carcinoma, Merkel Cell 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Small Cell Lung Cancer Recurrent 1 Safety Issues 1 Recurrent Liver Cancer After Liver Transplantation 1 Recurrence 1 Radiation Pneumonitis 1 Ovarian Neoplasms 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Lymphoma 1 Lung Neoplasms 1 Locally Advanced or Metastatic Solid Tumors 1 Liver Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1

Interventions

tislelizumab 1 pembrolizumab 1 atezolizumab 1 Water 1 Therapeutics 1 Surgical Procedures, Operative 1 Preoperative Exercise 1 Nutritional Support 1 Immunoglobulins, Intravenous 1 Exercise 1 Ethanol 1 Dosage Forms 1 Biological Therapy 1 Adiposity 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Urologic Neoplasms × atezolizumab × Clear all

NCT05038657 2022-10-03

AURORA

University Hospital Southampton NHS Foundation Trust

Phase 2 Unknown

Carcinoma, Squamous Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡